Announcements Trials
Browse Landscape

Status

Available 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 19Expanded_access 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma 1

Interventions

tazemetostat 2regorafenib 2nirogacestat 2avapritinib 2Trabectedin 2selinexor 1ripretinib 1omburtamab I-131 1olaratumab 1mifamurtide 1glucarpidase 1ganitumab 1fludarabine phosphate 1balstilimab 1anlotinib 1Whole-Body Irradiation 1Tacrolimus 1TH 302 1Sunitinib 1Proton Pump Inhibitors 1Mycophenolic Acid 1Imatinib Mesylate 1Hydrocortisone 1FANG vaccine 1Everolimus 1DOXO-EMCH 1Cytarabine 1Cord Blood Stem Cell Transplantation 1Carboxypeptidases 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Expanded_access × anlotinib × Sarcoma × Clear all
NCT05612191 2022-11-28

Catequentinib in Patients Who Have Completed an Advenchen Study (A Compassionate Use Trial)

Advenchen Laboratories, LLC

Available
Sarcoma

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡